Brief: Eloxx Pharmaceuticals Announces Submission Of Investigational New Drug Application For Zkn-013

Eloxx Pharmaceuticals

28/03/2023 23:31

March 28 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS ANNOUNCES SUBMISSION OF
INVESTIGATIONAL
NEW DRUG (IND) APPLICATION FOR ZKN-013
    * ELOXX PHARMACEUTICALS ANNOUNCES SUBMISSION OF
INVESTIGATIONAL
NEW DRUG (IND) APPLICATION FOR ZKN-013
    * ELOXX PHARMACEUTICALS INC - ADDITIONAL IND FILING FOR
ZKN-013
FOR TREATMENT OF FAMILIAL ADENOMATOUS POLYPOSIS EXPECTED IN
FIRST HALF OF 2023

Source text for Eikon:  ID:nGNX8CbKPS 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))